Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group
- 1 January 1969
- Vol. 23 (1), 109-112
- https://doi.org/10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Hormonal therapy in cancer of the breast.XVI. The effect of Δ1-testololactone on clinical course and hormonal excretionCancer, 1960
- Steroids and Experimental Mammary CancerPublished by Elsevier ,1960